Citadel Advisors’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.36M Sell
124,000
-83,100
-40% -$4.01M ﹤0.01% 3721
2025
Q4
$8.12M Buy
207,100
+110,300
+114% +$4.28M ﹤0.01% 3536
2025
Q3
$3.91M Sell
96,800
-59,400
-38% -$2.42M ﹤0.01% 4801
2025
Q2
$5.94M Sell
156,200
-28,900
-16% -$1.06M ﹤0.01% 3815
2025
Q1
$7.92M Sell
185,100
-27,200
-13% -$1.16M ﹤0.01% 3176
2024
Q4
$8.6M Sell
212,300
-26,200
-11% -$1.09M ﹤0.01% 3179
2024
Q3
$9.14M Sell
238,500
-63,400
-21% -$2.74M ﹤0.01% 3050
2024
Q2
$14.2M Sell
301,900
-112,400
-27% -$5.66M ﹤0.01% 2375
2024
Q1
$21.5M Buy
414,300
+23,600
+6% +$1.07M ﹤0.01% 1996
2023
Q4
$17.2M Sell
390,700
-70,300
-15% -$3.21M ﹤0.01% 2168
2023
Q3
$21.9M Buy
461,000
+74,600
+19% +$3.38M ﹤0.01% 1766
2023
Q2
$14.7M Sell
386,400
-101,800
-21% -$3.68M ﹤0.01% 2202
2023
Q1
$17.6M Sell
488,200
-30,300
-6% -$1.34M ﹤0.01% 2060
2022
Q4
$26.3M Buy
518,500
+210,800
+69% +$11M 0.01% 1678
2022
Q3
$14.2M Buy
307,700
+138,200
+82% +$6.6M ﹤0.01% 2293
2022
Q2
$7.49M Buy
169,500
+38,400
+29% +$1.98M ﹤0.01% 3085
2022
Q1
$7.09M Sell
131,100
-98,640
-43% -$4.25M ﹤0.01% 3529
2021
Q4
$7.74M Sell
229,740
-20,740
-8% -$741K ﹤0.01% 3515
2021
Q3
$8.24M Sell
250,480
-20,500
-8% -$566K ﹤0.01% 3410
2021
Q2
$8.53M Buy
270,980
+18,880
+7% +$507K ﹤0.01% 3355
2021
Q1
$6M Sell
252,100
-62,033
-20% -$1.33M ﹤0.01% 3865
2020
Q4
$4.51M Buy
314,133
+31,133
+11% +$365K ﹤0.01% 3860
2020
Q3
$2.31M Buy
283,000
+74,300
+36% +$767K ﹤0.01% 4460
2020
Q2
$1.99M Buy
208,700
+94,200
+82% +$657K ﹤0.01% 4578
2020
Q1
$309K Sell
114,500
-15,740
-12% -$207K ﹤0.01% 7293
2019
Q4
$3.05M Buy
130,240
+5,440
+4% +$116K ﹤0.01% 3759
2019
Q3
$2.87M Buy
124,800
+37,140
+42% +$850K ﹤0.01% 3911
2019
Q2
$2.25M Sell
87,660
-15,940
-15% -$497K ﹤0.01% 4314
2019
Q1
$3.75M Sell
103,600
-51,640
-33% -$1.77M ﹤0.01% 3413
2018
Q4
$4.49M Buy
155,240
+96,060
+162% +$4.14M ﹤0.01% 2943
2018
Q3
$3.88M Buy
59,180
+19,660
+50% +$1.27M ﹤0.01% 3342
2018
Q2
$2.58M Sell
39,520
-1,600
-4% -$100K ﹤0.01% 3709
2018
Q1
$2.26M Buy
41,120
+7,420
+22% +$440K ﹤0.01% 3535
2017
Q4
$2.25M Sell
33,700
-15,660
-32% -$924K ﹤0.01% 3474
2017
Q3
$2.91M Sell
49,360
-15,300
-24% -$748K ﹤0.01% 2968
2017
Q2
$2.85M Buy
64,660
+9,140
+16% +$474K ﹤0.01% 2725
2017
Q1
$3.25M Sell
55,520
-37,020
-40% -$2.22M ﹤0.01% 2497
2016
Q4
$5.43M Sell
92,540
-2,100
-2% -$120K 0.01% 1913
2016
Q3
$4.95M Buy
94,640
+57,640
+156% +$2.59M 0.01% 1998
2016
Q2
$1.44M Sell
37,000
-6,620
-15% -$242K ﹤0.01% 3115
2016
Q1
$1.33M Sell
43,620
-2,260
-5% -$52K ﹤0.01% 3130
2015
Q4
$1.17M Buy
45,880
+38,620
+532% +$1.41M ﹤0.01% 3391
2015
Q3
$234K Sell
7,260
-9,520
-57% -$365K ﹤0.01% 5931
2015
Q2
$925K Buy
16,780
+4,620
+38% +$294K ﹤0.01% 4059
2015
Q1
$678K Sell
12,160
-3,280
-21% -$206K ﹤0.01% 4471
2014
Q4
$1.07M Buy
15,440
+960
+7% +$81.7K ﹤0.01% 3685
2014
Q3
$1.54M Sell
14,480
-3,060
-17% -$337K ﹤0.01% 3175
2014
Q2
$2.08M Sell
17,540
-6,580
-27% -$762K ﹤0.01% 2705
2014
Q1
$2.58M Sell
24,120
-15,520
-39% -$1.47M ﹤0.01% 2393
2013
Q4
$3.58M Sell
39,640
-28,640
-42% -$2.61M ﹤0.01% 1968
2013
Q3
$5.92M Buy
68,280
+38,320
+128% +$3.34M 0.01% 1455
2013
Q2
$2.54M Buy
+29,960
New +$2.77M ﹤0.01% 2251

Other funds holding OVV

Citadel Advisors's OVV Position: Q1 2026 in Review

Citadel Advisors increased its Ovintiv (OVV) stake by 25% in Q1 2026, buying an estimated $57.9M and bringing the position to 5,922,629 shares worth $352M. The position accounts for 0.06% of the portfolio, ranked #265.

Citadel Advisors first reported a position in OVV in Q2 2013 and has held it in 51 quarters since. 610 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • Citadel Advisors held 5,922,629 shares of Ovintiv worth $352M as of Q1 2026.
  • Citadel Advisors bought 1,200,886 Ovintiv shares in Q1 2026, an estimated $57.9M.
  • Ovintiv made up 0.06% of Citadel Advisors's portfolio in Q1 2026, its #265 holding.
  • Citadel Advisors first reported a position in Ovintiv in Q2 2013 and has held it in 51 quarters since.
  • 610 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.